---
figid: PMC9484366__gutjnl-2021-326874f02
figtitle: Current therapies and new developments in NASH
organisms:
- Olea europaea
- Viridiplantae
- Pittosporum tobira
- Phocaeicola vulgatus
- Prevotella copri
- Homo sapiens
- Mus musculus
- gut metagenome
- Sterna hirundo
organisms_ner:
- Drosophila melanogaster
pmcid: PMC9484366
filename: gutjnl-2021-326874f02.jpg
figlink: /pmc/articles/PMC9484366/figure/F2/
number: F2
caption: Proposed primary care pathway versus standard care for patients with NAFLD,
  adapted from Srivastava et al. EFL, enhanced liver fibrosis; FIB-4, fibrosis-4 index;
  NAFLD, non-alcoholic fatty liver disease.
papertitle: Current therapies and new developments in NASH.
reftext: Jean-Fran√ßois Dufour, et al. Gut. 2022 Oct;71(10):2123-2134.
year: '2022'
doi: 10.1136/gutjnl-2021-326874
journal_title: Gut
journal_nlm_ta: Gut
publisher_name: BMJ Publishing Group
keywords: ''
automl_pathway: 0.9086276
figid_alias: PMC9484366__F2
figtype: Figure
redirect_from: /figures/PMC9484366__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9484366__gutjnl-2021-326874f02.html
  '@type': Dataset
  description: Proposed primary care pathway versus standard care for patients with
    NAFLD, adapted from Srivastava et al. EFL, enhanced liver fibrosis; FIB-4, fibrosis-4
    index; NAFLD, non-alcoholic fatty liver disease.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Low
  - eIF2alpha
  - eRF3
  - SF2
  - ci
  - tRNA:Pro-CGG-3-1
  - tRNA:Pro-CGG-1-1
  - tRNA:Pro-CGG-2-1
  - tRNA:Pro-CGG-2-3
  - tRNA:Pro-CGG-2-2
---
